FOXO1 and asthma: As Fig. 6A, B shown, miR-493-5p agomiR treatment significantly reduced the proportion of Th9 cells, and the protein production of FOXO1, IL-9 and IRF4 in OVA-induced asthma mice were significantly reduced (Fig. 6C, E–G).